Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems

Table 2

Primary and secondary outcomes.

Outcome	Carbapenem (n = 66)	Cefepime (n = 21)	Levofloxacin (n = 26)	value
Primary
Expired patients in hospital, n (%)	11 (16.6)	0 (0)	4 (15.4)	0.253
Secondary
Expired patients in ICU, n (%)	3 (4.5)	0 (0)	1 (3.7)	0.616
ICU length of stay, mean (SD)	9.8 (16.0)	7.8 (6)	5.4 (4.1)	0.805
Hospital length of stay, mean (SD)	12.1 (11)	11.1 (10.5)	11.1 (10.4)	0.685